The present invention relates to compounds according to formula (I) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
本发明涉及按照式(I)的化合物作为自体
脂肪酶抑制剂,以及利用这种化合物治疗和/或预防由增加的溶酶
磷脂酸
水平和/或自体
脂肪酶的激活引起、介导和/或传播的生理和/或病理条件,特别是不同癌症的治疗。